Skip to main navigation Skip to search Skip to main content

Efficacy and safety of bumetanide oral liquid formulation in children and adolescents aged from 7 to less than 18 years old with Autism Spectrum Disorder

Project Details

Short titleEfficacy and safety of bumetanide oral liquid formulation in children and adolescents aged from 7 to less than 18 years old with Autism Spectrum Disorder
StatusFinished
Effective start/end date1/01/19 → 31/12/21

Funding

  • Birmingham Women's and Children's NHS Foundation Trust